Search Results - takashi+sato+(unable+to+locate)

1 Results

Sort By:

Nanoparticle delivery of lung cancer therapeutic

Abstract: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths in developed countries. Despite the availability of several synergistic, targeted therapy regiments, the 5-year survival rate for NSCLC is only 15%. The poor prognosis of NSCLS is due in part to limitations of current treatments, which do not trigger an immune...

Published: 5/22/2024 | Inventor(s): Dennis Klinman, Takashi Sato (Unable To Locate)

Keywords(s): Immunotherapy, Nanoparticle, Non-small cell lung cancer, NSCLC

Category(s): Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Oncology